Effects of Vitamin D on Systemic Lupus Erythematosus Disease Activity and Autoimmunity: A Systematic Review and Meta-Analysis.

• Type of Material: Article
• Authors: Shayan A Irfan, Internal Medicine, Dow University of Health Sciences, Karachi, PAK.; Abid A Ali, Internal Medicine, Dow University of Health Sciences, Karachi, PAK.; Naqiha Shabbir, Internal Medicine, Dow University of Health Sciences, Karachi, PAK.; Hina Altaf, Dow Medical College, Dr. Ruth K. M. Pfau Civil Hospital Karachi, Karachi, PAK.; Ali Ahmed, Internal Medicine, Dow University of Health Sciences, Karachi, PAK.; Jafrikh Thamara Kunnath, Internal Medicine, Government Medical College, Kozhikode, IND.; Naga Vijaya L Divya Boorle, Internal Medicine, Wayne State University, Detroit, USA.; April K Miguel, Internal Medicine, University of the City of Manila, Manila, PHL.; Chia Chi Loh, Internal Medicine, Manipal University College Malaysia, Melaka, MYS.; Nikhila Gandrakota, Family Medicine, Emory University School of Medicine, Atlanta, USA.; Mirza M Ali Baig, Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
• Language: English
• Date: 2022-06
• Publisher: Cureus
• Publication Version: Final Published Version
• Copyright Statement: © 2022, Irfan et al.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.7759/cureus.25896
• Title of Journal or Parent Work: Cureus
• Volume: 14
• Issue: 6
• Start Page: e25896
• End Page: e25896
• Keywords: anti-dsdna; sledai; vitamin d; sle; systemic lupus erythematosus
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

This study aims to assess the role of vitamin D on systemic lupus erythematosus (SLE) patients and its effects on systemic lupus erythematosus disease activity index (SLEDAI), anti-double-stranded DNA (anti-dsDNA), C3, C4, and fatigue in patients with SLE. A systemic search was conducted using three electronic databases, i.e., PubMed/Medline, Cochrane Library, and Google Scholar. Review Manager 5.4.1 (The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark) was employed for statistical analysis. All studies meeting the inclusion criteria were selected. A random-effect model was used to pool the studies, and the result was reported in the standard mean difference (SMD) with its corresponding 95% confidence interval. Six randomized controlled trials were selected. Five outcomes were assessed (SLEDAI, anti-dsDNA, C3, C4, and fatigue) to evaluate the role of vitamin D in SLE patients. A significant decrease in SLEDAI (SMD = -0.85 (-1.12, -0.58); p < 0.00001; I2   = 42%) and a non-significant decrease in anti-dsDNA (SMD = -0.09 (-0.03, 0.12); p = 0.42; I2   = 0%) was noted. A significant increase in levels of C3 (SMD = 0.30 (0.09, 0.51); p = 0.006; I2 = 0%) and fatigue (SMD = -1.27 (-2.38, -0.16); p = 0.02; I2 = 56%) was noted when vitamin D was used. Insignificant difference was observed in C4 (SMD = 0.20 (-0.02, 0.41); p = 0.07; I2   = 0%). Vitamin D in SLE patients showed a significant decrease in SLEDAI scores and a significant increase in C3 levels. The effect of vitamin D on fatigue was inconclusive. No significant difference in anti-dsDNA and C4 levels was noted.